Cargando…

Inhibition of UCHL1 by LDN-57444 attenuates Ang II–Induced atrial fibrillation in mice

Atrial fibrillation (AF) is the most common human arrhythmia in clinical practice and may be promoted by atrial inflammation and fibrosis. Ubiquitination is an important posttranslational modification process that is reversed by deubiquitinating enzymes (DUBs). DUBs play critical roles in modulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Hai-Lian, Zhang, Yun-Long, Yang, Jie, Shu, Qing, Yang, Xiao-Lei, Yan, Xiao, Chen, Chen, Li, Zhi, Li, Hui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075865/ https://www.ncbi.nlm.nih.gov/pubmed/31700166 http://dx.doi.org/10.1038/s41440-019-0354-z

Ejemplares similares

Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells
por: Kobayashi, Eiji, et al.
Publicado: (2019)

UCH-L1 inhibitor LDN-57444 hampers mouse oocyte maturation by regulating oxidative stress and mitochondrial function and reducing ERK1/2 expression
por: Yuan, Pan, et al.
Publicado: (2020)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation
por: Cao, Wei, et al.
Publicado: (2021)

ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
por: Zhu, Xi, et al.
Publicado: (2021)

The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor
por: Bi, Hai-Lian, et al.
Publicado: (2020)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
por: Toljan, Karlo, et al.
Publicado: (2018)

Jessica Soldavini, MPH, RD, LDN, Wins Huddleson Award
Publicado: (2020)

Kaempferol Prevents Against Ang II-induced Cardiac Remodeling Through Attenuating Ang II-induced Inflammation and Oxidative Stress
por: Du, Yao, et al.
Publicado: (2019)

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)
por: Zhao, Yin, et al.
Publicado: (2020)

All-trans retinoic acid attenuates the progression of Ang II-induced abdominal aortic aneurysms in ApoE(−/−)mice
por: Xiao, Jie, et al.
Publicado: (2020)

Administration of USP7 inhibitor P22077 inhibited cardiac hypertrophy and remodeling in Ang II-induced hypertensive mice
por: Gu, Yu-Hui, et al.
Publicado: (2022)

Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
por: Liu, Tao, et al.
Publicado: (2023)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
por: Chopra, Pradeep, et al.
Publicado: (2013)

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice
por: Vollaire, Julien, et al.
Publicado: (2019)

AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation
por: Jiang, Teng, et al.
Publicado: (2018)

Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3
por: Wu, Yan, et al.
Publicado: (2022)

The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling
por: Liu, Li-Juan, et al.
Publicado: (2016)

Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients
por: Yang, Liu, et al.
Publicado: (2022)

Rapamycin attenuated podocyte apoptosis via upregulation of nestin in Ang II-induced podocyte injury
por: Shi, Huimin, et al.
Publicado: (2022)

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
por: Younger, Jarred, et al.
Publicado: (2014)

Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2
por: Williams, Eleanor, et al.
Publicado: (2018)

LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone
por: Shitole, Pankaj, et al.
Publicado: (2021)

Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series
por: McKenzie-Brown, Anne Marie, et al.
Publicado: (2023)

Molecular Characterization and Expression Profiles of Sp-uchl3 and Sp-uchl5 during Gonad Development of Scylla paramamosain
por: Han, Kunhuang, et al.
Publicado: (2018)

UCHL1 regulates oxidative activity in skeletal muscle
por: Gao, Hongbo, et al.
Publicado: (2020)

Ang-(1-7) attenuates podocyte injury induced by high glucose in vitro
por: Lu, Jianxin, et al.
Publicado: (2023)

Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
por: Chen, Yu-Yang, et al.
Publicado: (2016)

Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice
por: Hada, Yoshiko, et al.
Publicado: (2022)

UCHL1 regulated by Sp1 ameliorates cochlear hair cell senescence and oxidative damage
por: Li, Lihua, et al.
Publicado: (2023)

Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
por: Jin, Lu-Shen, et al.
Publicado: (2022)

Nucleolin promotes Ang II‐induced phenotypic transformation of vascular smooth muscle cells by regulating EGF and PDGF‐BB
por: Fang, Li, et al.
Publicado: (2020)

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation
por: Hu, Juan, et al.
Publicado: (2021)

Influence of the interaction between Ac-SDKP and Ang II on the pathogenesis and development of silicotic fibrosis
por: Zhang, Yi, et al.
Publicado: (2018)

Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation
por: Wang, Zhe, et al.
Publicado: (2023)

Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation
por: Saengklub, Nakkawee, et al.
Publicado: (2017)

The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
por: Rozpędek-Kamińska, Wioletta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jr7crgl9kbmvmvspmeqjjmsum6